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Alzheimer's disease (AD) is the most prevalent form of dementia worldwide.
Neuropathologically, it is characterized by the accumulation of amyloid-β (Aβ) in senile plaques and hyperphosphorylated (phospho) tau protein in neurofibrillary tangles that are accompanied by synaptic and neuronal loss mainly in the cortex and hippocampal formation (Hyman et al., 2012) . However, even in autosomal-dominant AD (ADAD), there is a decades-long, clinically silent prodromal phase of the disease characterized by biochemical and complex cellular alterations including early-onset neurovascular dysfunction (Kisler et al., 2017; Sweeney et al., 2019 Sweeney et al., , 2018 and further neuronal dystrophy, astrogliosis, and recruitment of microglia (Dubois et al., 2014; Sperling et al., 2011) . It has been also recently acknowledged that the therapies focusing on prevention can be effective only at the initiation of biochemical stress when irreversible cellular changes have not yet occurred (De Strooper and Karran, 2016) . Synapses are considered to be an early site of developing pathology in AD, and the synaptic loss highly correlates with cognitive impairment in AD patients (DeKosky and Scheff, 1990; Terry et al., 1991) .
Previous studies have shown that FR successfully reduces AD-related neuropathology and cognitive dysfunction in different animal models. Specifically, CR attenuated Aβ deposition in Squirrel monkeys (Qin et al., 2006) and various transgenic mouse models of Alzheimer's disease (Mouton et al., 2009; Patel et al., 2005; Schafer et al., 2015; Wang et al., 2005) . Furthermore, it has been reported that both, long-term CR and IF feeding ameliorate behavioral deficits in triple transgenic (3xTgAD) mice (Halagappa et al., 2007) . However, the accompanying decrease in the levels of Aβ and phospho-tau were not found in the hippocampus of mice subjected to IF suggesting that this dietary approach may protect neurons downstream of AD pathogenesis (Halagappa et al., 2007) . In line with the work on animal models, studies in humans reported that low calories intake reduces the risk of developing AD (Luchsinger et al., 2002) .
J o u r n a l P r e -p r o o f
Journal Pre-proof 5XFAD mice co-overexpress five human familial AD gene mutations, and their pathology recapitulate numerous pathological features of AD including inflammation, bloodbrain barrier (BBB) breakdown, synaptic changes and eventually progressive neuronal death (Giannoni et al., 2016; Oakley et al., 2006) . In the present study, we used 5XFAD transgenic mice to assess the effects of every-other-day feeding regimen on gliosis, synaptic plasticity, Aβ accumulation and BBB breakdown. Only female mice were used since previous reports suggest that female 5XFAD mice exhibit stronger response to treatments, changes of environment or genetic manipulations (Bhattacharya et al., 2014; Devi et al., 2010; Dinkins et al., 2015; Fragkouli et al., 2014; Sadleir et al., 2015) . EOD regimen was introduced at 2 months of age when Aβ deposition starts and the effects were analyzed in 6-month-old animals.
Methods

Animals
Transgenic 5XFAD mice and their background strain (B6SJLF1/J) used in this study were purchased from the Jackson Laboratory (Cat. No: 3484-JAX and 100012-JAX, Bar Harbor, Maine, USA) and maintained on B6/SJL genetic background by crossing 5XFAD transgenic male mice with B6SJLF1/J female mice. Female F1-offspring was used in this study. 5XFAD mice carry five familial Alzheimer's disease mutations: Swedish (K670N, M671L), Florida (I716V), and London (V717I) mutations in human amyloid precursor protein (APP695) and two mutations (M146L and L286V) in the human presenilin 1 protein under control of the neuron-specific Thy-1 promoter and express transgenes exclusively in neurons (Oakley et al., 2006) . 5XFAD mice start to develop amyloid deposits in hippocampal and cortical areas and exhibited neuroinflammation as early as 2 months of age (Oakley et al., 2006) . The J o u r n a l P r e -p r o o f Journal Pre-proof degeneration of synapses can be detected at 5 months of age, while deficits in hippocampal memory start to develop at the age of 4-6 months (Oakley et al., 2006; Ohno, 2009; Ohno et al., 2007) . The main advantage of the model is the robust age-related neuronal loss in the subiculum, cortical layer V, and the medial septum that is absent in other AD transgenic models (Eimer and Vassar, 2013) .
Feeding regimens
A total of 27 female mice were included in the study: 5XFAD transgenic mice (Tg), n=18
and their non-transgenic littermate controls (non-Tg), n=9. The animals were housed in plastic cages under standard conditions (23±2°C, 60-70% relative humidity, 12 hour light/dark cycle), and their health status was routinely controlled. The animals were provided ad libitum access to water and a standard laboratory diet. Food was available ad libitum (AL) until 2 months of age to all animals when 5XFAD mice were randomly (using random number generator) assigned to two differentially fed groups. The 5XFAD-AL group continued to receive food ad libitum (n=9), whereas the 5XFAD-EOD group was fed ad libitum every other day (EOD) for 4 months (n=9) ( Fig. 1A) . Additional four non-Tg female mice were fed EOD starting at 2 months of age for 4 months, and included for some of the Western blot analyses ( Figure 3C and Figure 5A and 5B), as a proof of principle of beneficial effects of EOD feeding regimen in the non-transgenic model. Body weighs of the animals were measured every two weeks. The EOD feeding regimen did not cause any caloric restrictions on the feeding day as animals had food available ad libitum and likely did not cause any vitamin and mineral deficiency as animals could compensate on the following day.
habituation, animals were placed in the OF arena with 2 identical, approximately 5 x 5 cm objects, placed in the top left and right corners of the testing area. Animals were allowed to explore the objects for 5 minutes then returned to their home cages. Short-term memory was tested after 15 minutes, and long-term memory after 24 hours, when one of the objects was replaced with object made of similar material, but different shape and color (novel object).
The animals were then reintroduced to the testing area and allowed to explore the area for 5 minutes.
Novel object location test was performed as previously described with modifications (Lazic et al, 2019) . Animals were habituated as in the above described NOR test. Similarly, as in NOR, after habituation, animals were placed in the OF arena with 2 identical, approximately 5 x 5 cm objects, placed in the top left and right corners of the testing area. Animals were allowed to explore the objects for 5 minutes then returned to their home cages. Short-term memory was tested after 1.5 hours, when one of the objects was relocated diagonally (novel) and the animals were reintroduced to the testing area and allowed to explore the area for 3 minutes. After each NOR and NOL trial, the testing area and the objects were thoroughly cleaned with 70% ethanol solution. All the NOR and NOL trials, including habituation, were recorded with a high resolution camera and the amount of time each animal spent exploring the objects was analyzed and presented as % time spent with novel objects over summarized time spent with novel and old objects. Any animal that showed a preference for either of the two identical objects before replacement with the novel location, or stayed in the corner during the habituation, was eliminated from the analysis.
Light/dark box
The light/dark box apparatus was used for the test of anxiety-like behavior as described previously (Pavković et al., 2017) . The chamber consisted of two parts made of white (26 x J o u r n a l P r e -p r o o f 26 x 34 cm) and black (17 x 26 x 34 cm) opaque Plexiglas with 10 x 10 cm door in the middle of the wall separating the two chambers. Mice were placed individually into the middle of the light chamber facing the wall and behavior was recorded by video camera attached to the ceiling for 10 minutes. Recorded material was analyzed for the latency to move into the light compartment and the number of transitions between chambers. After each trial, the box was thoroughly cleaned with 70% ethanol solution.
Tissue collection
At the age of 6 months, mice were anesthetized by intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg xylazine, and transcardially perfused with 0.1 M phosphate-buffer saline (PBS, pH = 7.4). The brains were quickly removed and one set was further processed for Western blot (WB) analyses as described below. The other set of brains was divided on ice into left and right hemispheres. The entire cortex of the right hemisphere was dissected under magnifying glass, snap-frozen in liquid nitrogen and stored at −80 °C for subsequent WB and ELISA analyses. The left hemispheres were fixed in fresh 4% paraformaldehyde (PFA) in PBS for 24 hours and cryoprotected in 30% sucrose in PBS at 4°C prior to freezing.
Brain sections, 30 µm thick, were cut on a cryostat (Leica, Wetzlar, Germany) and further stored free-float in a cryoprotective buffer (0.05 M phosphate buffer, 25% glycerol, and 25% ethylene glycol) at -20°C. The level of sections was approximately -1.656 to -2.255 from the bregma according to The Allan Mouse Brain Atlas (2008; Allen Institute for Brain Science, Allen Mouse Brain Atlas, http://mouse.brain-map.org/static/atlas).
Western blot
To obtain whole cell protein extracts, cortical tissue was homogenized and sonicated in 10 volumes of RIPA buffer (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1% NP-40, 0.1% SDS, J o u r n a l P r e -p r o o f 0.5% Triton X-100, 1 mM EDTA, 1 mM EGTA) containing protease and phosphatase inhibitors (Roche Diagnostics, Basel, Switzerland). Following the centrifugation at 20 000g at 4 °C for 30 min, the supernatants were collected and stored at −80 °C. The protein concentration was determined using the Micro BCA Protein Assay Kit (Pierce Biotechnology, Massachusetts, USA) and the Bovine Serum Albumin (BSA) as a standard.
Equal amounts of proteins (5, 10 or 15 μg per lane) were separated by SDS-polyacrylamide gel electrophoresis (10 or 12%) and blotted onto PVDF membranes (GE Healthcare, Little Chalfont, UK). To block non-specific binding, the membranes were incubated for 1h at room temperature (RT) in 3% BSA or 5% non-fat dry milk/TBST (150mM NaCl, 50mM Tris, pH 7.4, and 0.1% Tween20) and further incubated with primary antibodies overnight at 4°C in 2% blocking solution. Following several rinses in TBST, the membranes were incubated for 1h in appropriate Horse Radish Peroxidase (HRP)-conjugated secondary antibodies (see Table 1 for details on primary and secondary antibodies used). HRP-immunoreactive bands were visualized using enhanced chemiluminiscence (ECL, GE Healthcare, Little Chalfont, UK) and film exposure (Kodak Biomax). Each blot was subsequently re-probed with mouse anti-β-actin or goat anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH) antibody.
Signals were quantified densitometrically using Image Quant software (v. 5.2, GE Healthcare) and expressed as relative values, normalized to the corresponding signals of loading controls or Ponceau S. The levels of the target protein in Tg-AL and Tg-EOD mice were determined relative to the appropriate control value in non-Tg-AL mice that was set to 100%.
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Astrocytes
Mouse anti-GFAP (Millipore, MAB360) HRP-conjugated anti-mouse (Dako, P0260)
Tumor necrosis factor α
Mouse anti-TNF-α (Abcam, ab1793) HRP-conjugated anti-mouse (Dako, P0260)
Excitatory amino acid transporter 2
Rabbit anti-EAAT2 (Abcam, ab41621) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
Glutamic acid decarboxylase
Rabbit anti-GAD65 (Millipore, ABN101) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
Mouse anti-GAD67 (Millipore, MAB5406) HRP-conjugated anti-mouse (Dako, P0260)
γ-aminobutyric acid receptor
Rabbit anti-GABAA receptor α1 (Sigma-Aldrich, G4416)
HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370) Rabbit anti-GABAA receptor α5 (R&D Systems, PPS027)
HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
N-methyl-D-aspartate receptor subtype 2B
Rabbit anti-NMDAR2B (Cell Signaling Technology, 4212S) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
Growth associated protein 43
Rabbit anti-GAP-43 (Santa Cruz Biotechnology, sc-10786) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
Synaptophysin
Rabbit anti-synaptophysin (Santa Cruz Biotechnology, sc-9116) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
Post-synaptic density protein 95
Rabbit anti-PSD-95 (Millipore, 04-1066) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370)
Adducin
Mouse anti-adducin β (Santa Cruz Biotechnology, HRP-conjugated anti-mouse (Dako, P0260) Rabbit phospho-adducin (Santa Cruz Biotechnology, sc-12614) HRP-conjugated anti-rabbit (Santa Cruz Biotechnology, sc-2370) J o u r n a l P r e -p r o o f protein (GFAP) for detection of astrocytes; mouse anti-neuronal nuclear antigen (NeuN) to visualize neuronal cell bodies; mouse anti-SMI312 to detect neurites and goat anti-CD13 to visualize pericytes. To label brain vessels, sections were incubated with Dylight 488conjugated Lycopersicon esculentum lectin together with primary antibodies. After incubation in primary antibodies, and rinsing with PBS, sections were incubated with fluorophore-conjugated secondary antibodies (see table below regarding detailed information on antibodies used) for 1 hour at RT. For detection of Aβ plaques, the sections were incubated in 1% aqueous thioflavin-S (Sigma, T1892) for 8 minutes and rinsed in 80% ethanol, 95% ethanol and distilled water. All the sections were placed on the slides and mounted with DAPI Fluoromount (Southern Biotech, 0100-20). 
Microglia
Rabbit anti-Iba-1(Wako, NC9288364) Alexa fluor-568-conjugated anti-rabbit (Invitrogen, A11036)
Astrocytes
Mouse anti-GFAP (Millipore, MAB360) Alexa fluor-568-conjugated anti-mouse (Invitrogen, A-11004) Representative images of higher magnification were taken on Nikon confocal microscope with standardized gain, digital offset and laser intensity, and these conditions were kept identical for all groups.
Neuronal cell bodies
Quantification of NeuN-positive neuronal cell bodies and SMI312-positive axonal spheroids
Quantification was performed from images taken on BZ9000 fluorescent microscope at 20x magnification. Analyses were done using NIS Nikon software or threshold processing ( Representative images were taken on Nikon confocal microscope with standardized gain, digital offset and laser intensity, and these conditions were kept identical for all groups.
Thioflavin S analysis of plaques
Thioflavin-S-positive plaques were determined from the images taken on AxioVision microscope (Carl Zeiss) fluorescent microscope in single plain on 5x magnification. The images were subjected to threshold processing (Otsu) using ImageJ and the total number of plaques and the size of the analyzed cortical and hippocampal area were measured. In each animal, 5 fields from the cortex were imaged and analyzed in 2-4 nonadjacent sections from 
Statistical analyses
For analyses of A load ( Figure 1B and 1C) , F test was conducted to determine similarity in the variances between the two groups that are statistically compared, and statistical significance was analyzed by Student's t-test. For multiple comparisons, one-way analyses of variance (ANOVA) followed by Tukey's post hoc test was used to determine statistical significance between three experimental groups. For four experimental groups, two-way ANOVA was used to determine interaction between two factors (diet and genotype) and
Tukey's post hoc test to determine statistical significance. For all analyses, D'Agostino and
Pearson normality test was used to test normality of the data and appropriate test to determine statistical significance was applied using GraphPad Prism 7.0 software. A p value of less than J o u r n a l P r e -p r o o f 0.05 was considered to be significant. All data are shown as scatter plots with single points per mouse, and boxplots representing mean ± SD, as indicated in the figure legends. symptoms commonly found in patients with dementia (Kivimäki et al., 2018) . We therefore firstly examined the appearance and general behavior of animals in all groups studied. The 5XFAD-EOD mice did not phenotypically differ from 5XFAD-AL or non-Tg-AL at the age of 6 months. Additionally, the body weights were measured prior to and every two weeks for the duration of experiment, and body weight gain was calculated for each animal prior to tissue collection. A decrease trend, without reaching statistical significance (p=0.069, oneway ANOVA, data not shown) in body weight gain normalized to the initial weight for each mouse was observed between 5XFAD-AL and 5XFAD-EOD animals (body weight gain/starting body weight for 5XFAD-AL animals was 0.088 ± 0.052 and for 5XFAD-EOD animals was 0.015 ± 0.037). Serum glucose levels were not changed in non-Tg-AL, 5XFAD-AL and 5XFAD-EOD experimental groups indicating normal glucose metabolism with this particular type of FR regimen (data not shown).
Results
General health and body weights of the animals
J o u r n a l P r e -p r o o f Every-other-day feeding does not affect Aβ load and blood-brain barrier permeability in the cortex of 5XFAD mice Aβ is produced by enzymatic cleavage of its precursor, amyloid precursor protein (APP). It further polymerizes and forms senile plaques that represent a major pathological hallmark of AD. We therefore evaluated the effects of EOD on plaque deposition and Aβ production in the cortex of 5XFAD mice. To visualize fibrillar plaques, coronal brain sections were stained with histochemical dye, Thioflavin S (ThS). There was no difference in ThS-positive plaque load in 5XFAD-AL and 5XFAD-EOD group in the cortex and hippocampus regardless of the size of plaques quantified (total number of plaques per µm 2 ) (p=0.2617 for cortex and p=0.0851 for hippocampus, two-tail Student's t-test; Fig. 1B ). Other quantified parameters including number of plaques < 100 µm 2 , number of plaques > 100 µm 2 , averaged plaque size, and the total area covered in plaques were also not altered in 5XFAD-EOD when compared to 5XFAD-AL mice (data not shown). As Aβ42 represents the dominant Aβ peptide present in brains of 5XFAD mice (Oakley et al., 2006; Wittnam et al., 2012) , we evaluated the total Aβ42 in the cortical and hippocampal homogenates by ELISA. No changes in Aβ42 levels were found 5XFAD-EOD when compared to 5XFAD-AL mice (p=0.2782, two-tail Student's t-test; Fig. 1C ).
At 4 months of age, 5XFAD mice exhibit BBB breakdown as previously shown by others (Giannoni et al., 2016; Kook et al., 2012; Montagne et al., 2017; Park et al., 2017; Storck et al., 2016) . Therefore, we finally examined if EOD has as an effect on BBB homeostasis. We performed WB against mural cells marker, platelet-derived growth factor receptor β (PDGFRβ) and showed decreased protein levels of PDGFRβ in 5XFAD-AL mice when compared to their non-Tg-AL controls (p=0.0057, one-way ANOVA; Fig. 2A ).
Because PDGFRβ is expressed predominantly by pericytes (Sagare et al., 2015) , we performed immunohistochemistry to examine pericyte coverage in capillaries (< 6 µm in J o u r n a l P r e -p r o o f diameter) and found a decrease in pericyte coverage in 5XFAD-AL mice (p=0.0231, one-way ANOVA; Fig. 2B ). Additionally, we examined leakage of blood-derived protein immunoglobulin G (IgG) with WB and found a 2-fold increase of IgG in 5XFAD-AL p=0.0151, one-way ANOVA) and 5XFAD-EOD (p=0.0286, one-way ANOVA) mice comparing with non-Tg-AL (Fig. 2C ). However, we found no change in 5XFAD-EOD mice when compared to AL-fed 5XFAD animals in none of the parameters regarding BBB permeability examined (p=0.9999, one-way ANOVA, Fig. 2A; p=0 .9155, one-way ANOVA, Fig. 2B and p=0 .8432, one-way ANOVA, Fig. 2C ).
Every-other-day feeding increases inflammation in the cortex of 5XFAD mice
5XFAD mice start to exhibit neuroinflammation as early as 2 months of age (Giannoni et al., 2016; Landel et al., 2014) . Thus, we next examined neuroinflammatory status and gliosis in EOD-fed mice. Microglial activation was assessed by immunostaining using microglial marker ionized calcium-binding adapter molecule 1 (Iba-1), and activation of astrocytes was assessed with immunostaining and WB using glial fibrillary acidic protein (GFAP) (Fig. 3A-C) . A significant 4-fold increase in the activation of Iba1-positive microglial cells was detected in 5XFAD-AL group of animals in comparison to their non-Tg-AL littermates (p=0.0017, one-way ANOVA) which was further increased in 5XFAD-EOD mice by 2-fold (p=0.0025, one-way ANOVA; Fig. 3A ). 5XFAD-AL mice also displayed an extensive increase in hypertrophied astrocytes and GFAP protein level in the cortex (by 3-fold) when compared to non-Tg-AL mice (Fig. 3B p=0 .0003, one-way ANOVA; Fig. 3C p<0.0001, twoway ANOVA). Namely, GFAP immunostaining and Western blot revealed increased astrocytic reactivity and/or proliferation in 5XFAD-EOD mice in comparison to 5XFAD-AL mice by 30% (p=0.0079, one-way ANOVA; Fig. 3B ) and a trend towards increase in 5XFAD-EOD mice in comparison to 5XFAD-AL mice by 17% (p=0.0644, two-way J o u r n a l P r e -p r o o f ANOVA; Fig. 3C ). However, a slight decrease trend was observed in non-Tg animals on EOD in comparison to non-Tg AL mice (p=0.7692, two-way ANOVA). Two-way ANOVA analyses further revealed that there is a significant interaction between factors genotype and dietary regimen (p=0.0229) with the genotype as a main effect (p<0.0001). In addition, tumor necrosis factor alpha (TNF-α), a potent pro-inflammatory cytokine involved in neuronal damage and disease pathogenesis, was assessed by immunoblotting. In line with the increased reactivity and/or proliferation of glial cells, TNF-α protein levels were increased in 5XFAD-AL and further increased in 5XFAD-EOD mice when compared to their non-Tg-AL controls by 25% (p=0.483, one-way ANOVA) and 50%, respectively (p=0.025, one-way ANOVA; Fig. 3D ). Additionally, analyses of p38 mitogen-activated protein kinase (p38 MAPK), a kinase that is involved in production of cytokines by glial cells and inflammation-induced neurotoxicity and is upregulated in the presence of cytokines (Bachstetter and Van Eldik, 2010) , revealed an increase of its phosphorylated form by 30% (p=0.0052, one-way ANOVA; Fig. 3E ) and total p38 levels by 25% (p=0.0258, one-way ANOVA; Fig. 3F ) in the cortex of 5XFAD-EOD comparing to 5XFAD-AL animals. The ratio between phosphorylated and total form of p38 between 5XFAD-AL and 5XFAD-EOD mice, however, remained unchanged (p=0.6465, one-way ANOVA; Fig. 3G ). Astrocytes-specific glutamate transporter, excitatory amino acid transporter 2 (EAAT2) (Vanlandewijck et al., 2018) , showed a trend towards upregulation in 5XFAD-EOD mice of ~30% when compared to 5XFAD-AL mice (p=0.0636, one-way ANOVA; Fig. 3H ), which is consistent with previous reports that reactive astrocytes exhibit upregulation of EAAT2 (Desilva et al., 2008) . Taken together, these data imply that EOD regimen intensifies the already existing inflammation in the cortex of 5XFAD mice.
J o u r n a l P r e -p r o o f
The effects of every-other-day feeding on glutamatergic and GABAergic systems,
neuronal health and behavior in 5XFAD mice
The increased expression of glutamate transporter EAAT2 prompted us to further examine the levels of proteins involved in the synthesis of γ-aminobutyric acid (GABA) and, thus, elimination of glutamate ( Fig. 4A-D) . Major GABA synthesis enzymes, glutamic acid decarboxylases (GAD), GAD67 and GAD65, were examined and our data showed decreased GAD67 (non-Tg-AL vs. 5XFAD-EOD p=0.0033, one-way ANOVA) and a trend towards decrease of GAD65 (non-Tg-AL vs. 5XFAD-EOD p=0.0559, one-way ANOVA) in 5XFAD-EOD animals compared to non-Tg-AL ( Fig. 4A and 4B ). However, we found no change in two GABA receptors, GABAA-R-α1-(non-Tg-AL vs. 5XFAD-EOD p=0.1611, one-way ANOVA) and α5 (non-Tg-AL vs. 5XFAD-EOD p=0.9711, one-way ANOVA), in 5XFAD-EOD animals ( Fig. 4C and 4D ).
Slight synaptic degenerative alterations have been reported to occur already in 6month-old 5XFAD animals (Oakley et al., 2006) , thus we next examined the effects of EOD on expression of synaptic markers. Given previously established beneficial effects of EOD feeding regimen on expression of synaptic proteins in non-transgenic animals by our lab and others (Lončarević-Vasiljković et al., 2009; Mladenovic Djordjevic et al., 2010; Singh et al., 2015) , we analyzed presynaptic marker, growth associated protein of 43 kDa (GAP-43) and postsynaptic marker, postsynaptic density protein 95 (PSD-95), on Western blot in non-Tg mice fed AL and EOD and 5XFAD mice fed AL and EOD. We found a slight increase (8%, p=0.5379, two-way ANOVA; Fig. 5A ) in GAP43 protein levels in non-Tg-EOD when compared to non-Tg-AL, while a significant decrease (p=0.0408, two-way ANOVA) in GAP43 protein levels was detected between 5XFAD-EOD and 5XFAD-AL mice.
Additionally, GAP43 protein levels were decreased by ~30% in 5XFAD-EOD mice when compared to non-Tg-EOD group (p=0.0002, two-way ANOVA). When analyzing PSD95 J o u r n a l P r e -p r o o f protein levels (Fig. 5B) , we found a significant increase in non-Tg mice fed EOD when compared to non-Tg-AL mice by 25% (p=0.0173, two-way ANOVA), as expected. However, EOD regimen significantly decreased PSD95 protein levels in 5XFAD mice, by 32% compared to 5XFAD-AL and by 57% compared to non-Tg-EOD group (p=0.0340, and p<0.0001, two-way ANOVA, respectively). We further found a significant interaction, p=0.0081 and p=0.0003, between dietary regimen and genotype when analyzing GAP43 and PSD95 protein levels, respectively, with genotype as a main effect in both cases (p=0.0001
for GAP43 analysis and p<0.0001 for PSD95 analysis). We further analyzed protein levels of additional markers of synaptic plasticity, synaptophysin and adducin (Add), in non-Tg-AL, 5XFAD-AL and 5XFAD-EOD mice. Analysis of WB data revealed a significant decrease by 35%, in synaptophysin levels in 5XFAD-AL animals in comparison to non-Tg-AL mice (p=0.0105, one-way ANOVA; Fig. 5C ). In 5XFAD-EOD animals, however, a significant decrease in the level of synaptophysin was present by and 43% when compared to 5XFAD-AL mice (p=0.0086, one-way ANOVA; Fig. 5C ). Furthermore, the levels of Add and phosphorylated adducin (p-Add), a regulator of synapse stability, were decreased in relation to genotype and the feeding regimen applied ( Fig. 5D and 5E ). In 5XFAD-AL animals, p-Add and Add protein levels were reduced by 40% (p=0.0268, one-way ANOVA), and 35% (p=0.0293, one-way ANOVA), respectively, in comparison to the levels observed in their non-Tg-AL littermates. Four months of EOD resulted in further decrease in protein levels of phospho-Add (p=0.0392, one-way ANOVA; Fig. 5D ) by~40%, while the levels of total Add did not change between 5XFAD-AL and 5XFAD-EOD mice groups (p=0.6155, one-way ANOVA; Fig. 5E ). In addition, protein level of NR2B-containing N-methyl-D-aspartic acid (NMDA) receptor, NMDAR2B, directly involved in excitotoxicity and neuronal apoptosis (Liu et al., 2007) , underwent remarkable increase in cortical homogenates of 5XFAD-AL animals by 47% above the level detected in non-Tg-AL animals (p=0.0082, one-way J o u r n a l P r e -p r o o f ANOVA; Fig. 5F ). A significant genotype-induced increase of NMDAR2B protein level in 5XFAD-AL animals was additionally increased by EOD by 97% (p=0.0002, one-way ANOVA; Fig. 5F ) potentially indicating alterations in glutamatergic signaling.
Because we showed a decrease in synaptic proteins and an increase in NMDAR2B in EOD-fed 5XFAD mice, we performed SMI312 and NeuN double immunohistochemistry, to examine neuronal health. We found significantly increased number of axonal spheroids, a feature of dystrophic neurites in 5XFAD-EOD when compared to non-Tg-AL (p=0.0003, one-way ANOVA) and 5XFAD-AL (p=0.0155, one-way ANOVA) mice groups (Fig. 5G) , as well as decreased number of NeuN-positive cells in 5XFAD-EOD group when compared to non-Tg-AL group (p=0.0483, one-way ANOVA; Fig. 5G ). Our results imply that 4 months of EOD impairs synaptic plasticity and promotes neuronal injury in 5XFAD mice, and that these deficits could involve glutamate and GABA signaling.
Finally, we assessed behavioral performances of non-Tg-AL, 5XFAD-AL and 5XFAD-EOD mice. We found that 5XFAD-EOD mice exhibit a significant decline in behavior in comparison to non-Tg-AL mice when tested on short-term memory in NOR (p=0.0105 one-way ANOVA, Fig. 6A ) and NOL (p=0.0134 one-way ANOVA, Fig. 6C ), matching the data on neuronal cell numbers (Fig. 5G) , while there is only a trend towards decreased short-term memory in NOL between 5XFAD-AL and 5XFAD-EOD groups (p=0.0936, Fig. 6C ). Furthermore, a trend towards increased anxiety-like behavior in light/dark box test was observed between non-Tg-AL and 5XFAD-EOD group (p=0.0601 one-way ANOVA; Fig. 6D and p=0 .0422 one-way ANOVA; Fig. 6E ). 5XFAD-EOD mice, however, did not exhibit any signs of mobility deficits and abnormal stereotypic behavior in open field (p=0.9159 one-way ANOVA; Fig. 6F and p=0 .2622 one-way ANOVA; Fig. 6G ), or in long-term memory NOR testing (p=0.8805 one-way ANOVA; Fig. 6B ) in comparison to their non-Tg-AL controls. Numerous data provide evidence for protective effects of long-lasting FR paradigms, both CR and EOD, on age-and pathology-related impairments in a variety of organisms (Fontana and Partridge, 2015) . Similarly to CR, EOD regimen was clearly shown to improve age-related alterations in synaptic integrity (Mladenovic Djordjevic et al., 2010; Singh et al., 2012; Speakman and Mitchell, 2011) and cognitive function following excitotoxicity and ischemic insults (Anson et al., 2003; Fann et al., 2014; Kaur et al., 2008; Parinejad et al., 2009; Sharma and Kaur, 2005) . Although the effects of EOD regimen in the brain have also been associated with reduced inflammation and oxidative stress, and increased production of neurotrophic factors such as brain-derived neurotrophic factor (Martin et al., 2006) , a recent comprehensive study revealed that EOD-induced increase in longevity could be explained by delays in life-limiting neoplastic disorders rather than a general slowing down of the aging process (Xie et al., 2017) . Therefore, contrary to the dogma, even though EOD extends J o u r n a l P r e -p r o o f lifespan, it does not affect most age-related processes, so our observation of lack of beneficial effects is partially supported by this extensive evaluation of age-dependent effects of EOD.
In AD animal models, similarly to CR, the effects of EOD were mostly recognized as beneficial (Halagappa et al., 2007; Mouton et al., 2009; Patel et al., 2005; Schafer et al., 2015; Wang et al., 2005) . However, the results across different studies that examined the effects of EOD on amyloid-β and tau levels, are inconsistent. For example, one study showed that EOD leads to an increased clearance of amyloid-β from brain in APP/PS1 mice by inducing a change of aquaporin 4 polarity (Zhang et al., 2017) , another study reported that EOD ameliorates behavioral deficits in 3xTgAD mice without alterations in amyloid-β or tau levels (Halagappa et al., 2007) , and one study showed that fasting does not affect extracellular Aβ in 5XFAD mice (Chen et al., 2015) , similarly to our observations. However, in certain situations, CR can have negative effects, consistent with our results. It has been shown that CR has deleterious effects on longevity and cognition when introduced at very young or old age (Cardoso et al., 2016; Forster et al., 2003) , and that gender and even minor genetic differences play a significant role in achieving the protective effects within the same species (Sohal et al., 2009 ). There are also evidences that CR can aggravate the toxicity to some compounds (Seki et al., 2000) , decrease resistance to infection (Gardner, 2005; Goldberg et al., 2015; Kristan, 2018; Sun et al., 2001) , and prolong wound healing (Hunt et al., 2012) , but the mechanisms for the reported effects are not clear.
Numerous side effects are also indicated in humans practicing FR including hypotension, hormonal irregularities, osteoporosis, altered cold sensitivity, loss of strength and the development of psychological conditions such as depression and dysphoria (Dirks and Leeuwenburgh, 2006) , implying that FR has rather selective than universal effects, and that the type and severity of pre-existing pathology, duration, age of onset, and the severity of FR J o u r n a l P r e -p r o o f can significantly influence its final molecular, behavioral, and functional outcome (Mattson et al., 2017; Sohal and Forster, 2014; Todorovic et al., 2018) .
As beneficial effects of FR have been proposed to be dependent on the metabolic state of the organism (Sacher, 1977) , the imbalance between energy intake and energy expenditure in conditions of increased energy demand, could therefore, limit proper body maintenance.
Negative energy balance caused by FR is associated with an increased susceptibility to diseases (Dorighello et al., 2014; Hamadeh et al., 2018) , while chronic inflammation represents one of the factors implicated in the control of energy spending (Straub, 2017) . Our data show that EOD regimen exacerbates already existing inflammation in the brain of 5XFAD females, and this amplification of inflammation by EOD is previously reported as an additional increase in cytokine production in a model of Poly(I:C)-induced inflammation (Zenz et al., 2019) . Previous studies had suggested that activation of neuroinflammation is one of the central and early steps in the pathogenesis of AD (Heneka et al., 2015) , and that inflammation acts independently on several pathways that in turn synergistically contribute to synaptic plasticity deficits and neuronal injury. Microglia have a central role in mediating the effects of neuroinflammation, as activated microglia release a number of cytokines and chemokines, activating in turn many signaling pathways (Rao et al., 2012) . Previous studies have shown that TNFα can activate p38 MAPK signal transduction in microglia or other cell types of the central nervous system (astrocytes and neurons), which in turn can induce the release of proinflammatory cytokines from microglia, forming a vicious circle contributing to disease progression and severity (Bachstetter and Van Eldik, 2010) . Furthermore, activated p38 MAPK can directly cause synaptic dysfunction in AD .
Additionally, TNFα can regulate transcription of a number of genes including proinflammatory products of the arachnoid acid cascade, influencing further signal transduction, neuronal activity and apoptosis, and reduction of synaptic markers such as J o u r n a l P r e -p r o o f synaptophysin (Rao et al., 2012) . The imbalance in GABAergic and glutamatergic synapses can also be a consequence of neuroinflammation (El-Ansary and Al-Ayadhi, 2014), as TNFα induces a rapid and persistent decrease of inhibitory synaptic strength (Pribiag and Stellwagen, 2013) , and thus, regulates neuronal circuit homeostasis in a manner that may exacerbate excitotoxic damage resulting from neuronal insults (Stellwagen et al., 2005) .
Another important player of inflammation is nuclear factor kappa B (NFκB), and literature reports that NFκB is critically involved in induction of EAAT2 expression and its transport activity (Ghosh et al., 2011) . Therefore, the upregulation of EAAT2 in 5XFAD-EOD group of our experimental paradigm could be due to the increased inflammatory response.
The exact underlying mechanism by which EOD exacerbates inflammation and neuronal deficits remains, however, unknown. Our previous studies have shown that during aging, EOD can modify the levels and subcellular localization of phosphorylated form of glucocorticoid receptor (pGR) (Tesic et al., 2015) , which could further modulate the cytokine production. Whether or not the pGR signaling is altered in EOD-treated 5XFAD females, and whether this could be the missing link in the explanation how EOD feeding exacerbates inflammation, remains to be investigated in the future. Furthermore, to address the complexity of our data, changes in autophagy and insulin signaling pathways, in addition to changes in oxidative stress, hormonal imbalance, alterations in cerebral blood flow or existing microbiota in the gastrointestinal tract could also be of interest for future studies.
Conclusion
Our results provide first in vivo demonstration that EOD has harmful effects in the cortex of 5XFAD females, in contrast to the well accepted FR-induced protective effects on neurons and synapses during aging (Guo et al., 2000; Mladenovic Djordjevic et al., 2010) , confirmed as well in our experimental paradigm with non-Tg animals. Although causal relationship J o u r n a l P r e -p r o o f between intermittent fasting and the disease progression cannot be established based on this study, the results suggest that decision of using FR in AD patients should be carefully made.
One should thoroughly consider all the effects of FR on various aspects of the pathology as well as the cognitive and behavioral status and overall health. Further studies on the effects of FR in AD pathology are warranted in order to more comprehensively determine degree, duration, age of FR onset and whether it should be applied pre-symptomatically or after the onset of symptoms, to achieve optimal health, promote neuronal resistance to insults and reduce brain injury. Furthermore, as the neuroinflammatory response in 5XFAD mice starts in early age, the pathology is probably too robust to study beneficial effects of intermittent feeding. Future studies could answer if effects of EOD feeding would be any different if the treatment in 5XFAD mice started before the neuroinflammation onset or if possibly different FR paradigm, such as CR regimen, is applied instead. 
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